Healthcare

Humana boosts full-year profit guidance and the stock rises while SoFi falls after announcing an underwritten public offering of $1.5 billion of common shares.

Wednesday, GE HealthCare reported earnings per share of $1.06 from sales of just over $5 billion. Wall Street was looking for EPS of 92 cents from sales of just under $5 billion.

Second-quarter adjusted earnings came in at $6.27 a share on sales of $32.4 billion. beating analysts' expectations.

Retirees might spend more than $172,000 on healthcare, Fidelity estimates. How to ease the sting.

Revenue at SoFi jumps 44%, UnitedHealth slides after restoring financial guidance, and Sarepta soars after being notified by the FDA the company may lift its voluntary pause on shipments of Elevidys for ambulatory patients with Duchenne muscular dystrophy.

Tech and financials are booming. Other sectors are struggling.

The company sees 2025 adjusted earnings of ‘at least’ $16 a share and revenue in the range of $445.5 billion to $448 billion.

Tesla rises after President Donald Trump says he struck a deal to set 15% tariffs on goods from the European Union, including automobiles.

The health sciences company posts better-than-expected adjusted earnings and revenue but trims its guidance.

The healthcare sector, including managed-care firms and drug powerhouses, is vastly underperforming the S&P 500 index. Here are five problems they need to address.

The outlook for shares is bleak after another batch of worrying headlines.

Intel stock falls after the chip maker reports a wider loss in the second quarter, while Centene rises even as it posts a surprise quarterly loss.

The company reported a surprise quarterly loss, the latest blow for the embattled health insurance industry.

President and CEO Gail K. Boudreaux bought shares of the health insurer after Elevance slashed guidance.

Intel offers rosy outlook, railroad megamerger talks are on, UnitedHealth suffers another blow, and more news to start your day.

Net income at Tesla falls 16% in the second quarter, while Alphabet says quarterly cloud revenue jumped 32%.

The healthcare company says it is “complying with formal criminal and civil requests” from the Justice Department.

The injectable medicine company raises its full-year earnings and revenue expectations.

Cassidy, a Louisiana Republican, has a proposal to touch what is known as the third rail of American politics: Social Security.

Shares in TransMedics soared tenfold in the last three years, plunged in January, and have recovered of late.

Tesla and Alphabet report quarterly earnings after the closing bell Wednesday, while Texas Instruments tumbles after issuing a disappointing profit forecast.

The market is headed for a seasonally difficult period in late summer, but there is no catalyst for a longer-lasting decline.

General Motors tops earnings estimates but the stock falls, and Lockheed Martin stock declines after the defense contractor’s earnings included charges of $1.7 billion that took Wall Street by surprise.

Sarepta says it will continue to ship Elevidys despite FDA requests that it stop shipments of the Duchenne muscular dystrophy gene therapy, while Verizon tops earnings expectations and raises 2025 guidance.

A Goldman ranking of S&P 500 sectors by price/earnings ratios reveals opportunities in healthcare stocks.